1. Introduction {#Section1}
===============

Approximately 2 million soft tissue filler procedures were performed in the United States in 2012[@B1]. Thus, it is more important than ever to study on soft tissue filler. Soft tissue augmentation is a continuing problem in plastic and reconstructive surgery due to not long-lasting. Ideally, injectable filler material should be safe, effective, long-lasting, and biocompatible [@B2]. Injectable filler is advantageous not only because it minimizes the risk of operative infections, scarring, and operative costs, but also because multiple defective sites can be filled simultaneously. Recent studies have evaluated the use of long-lasting fillers for adipose tissue engineering.

Advantages of fat grafting include biocompatibility, versatility, stability, and natural appearance [@B3], [@B4], [@B5], [@B6]. Adipose tissue can also be obtained safely and with minimal donor site morbidity by using minimally invasive liposuction techniques [@B7], [@B8], [@B9]. However, cosmetic outcomes are unpredictable due to unresolved problems such as fat necrosis after grafting and high resorption rate, which can reportedly exceed 50 percent [@B10]. Despite the improved outcomes obtained by recent refinements in conventional fat grafting techniques [@B11], [@B12], improved optimal fillers are still needed.

A long-lasting filler should incorporate a biocompatible scaffold that defines the required volume, promotes host integration, and degrades as it is replaced by new adipose tissue. Therefore, scaffolds must include naturally derived or synthetic tissue substitutes. Naturally derived materials include hyaluronic acid [@B13], [@B14], collagen [@B15], [@B16], [@B17], chitosan [@B18], [@B19], and alginate [@B20], [@B21]; synthetic materials include polyglycolic acid (PGA) [@B22], [@B23], [@B24], poly(DL-lactide-co-glycolide) (PLGA) [@B23], [@B25], [@B26], poly(ethylene glycol) diacrylate (PEGA) [@B27], [@B28] and so on. All these materials are designed to minimize immune rejection and resorption. Thus, key factors in filler design are mechanical properties, degradation characteristics, immunogenicity, and cellular response to the scaffold [@B29].

Hyaluronic acid (HA)-based gels are also widely used injectable materials [@B2]. The most popular is RESTYLANE^®^ (Hyaluronic acid gel, HA gel, <http://www.restylaneusa.com>) [@B30], a non-animal, stabilized hyaluronic acid (NASHA) produced by fermentation in equine streptococci cultures. Various filler products are differentiated by hyaluronic acid concentration, chemical cross-linking, and particle size. HA gel has good biocompatibility and virtually no immunogenicity [@B31]. However, because catabolic processes, which are mediated by receptor binding and intracellular degradation [@B32], persist for 6 to 12 months after injection [@B33], repeated injections are needed for long-term results.

Recent *in vivo* [@B34], [@B35] and *in vitro* [@B36] studies of hASCs have evaluated the use of various biocompatible scaffolds for adipose tissue engineering. Adipose tissue has also been successfully engineered in predefined shapes and in three dimensions by the authors and other researchers [@B35], [@B37]. An effective tissue-engineering strategy must ensure that, as cells grow, the scaffolding material degrades or is absorbed and eventually yields a new mass of adipose tissue to maintain the tissue contour [@B7].

Hyaluronic acid-based materials have been studied for engineering various tissues, including skin [@B38], adipose tissue [@B13], cartilage [@B39], and bone [@B40]. These scaffolding materials are apparently suitable culture carriers, and *in vivo* animals\' models reveal full maturation into adipocytes [@B41]. We hypothesized that *de novo* adipose tissue formation could be achieved by pure hyaluronic acid scaffolding cell delivery and tissue engineering. Therefore, this study evaluated a technique for culturing hASCs on HA gel to obtain soft tissue filler that was sufficiently long-lasting for engineering adipose tissue.

2. Materials and methods {#Section2}
========================

2.1. Isolation of human adipose-derived stem cells from adipose tissue {#Section2.1}
----------------------------------------------------------------------

With patient\'s informed consent and IRB approved by the review board of Kaohsiung Medical University Hospital (KMUH-IRB-960443), the hASCs were isolated from subcutaneous adipose tissue from female donors who underwent transverse rectus abdominis myocutaneous (TRAM) flap for breast reconstruction. The hASCs were isolated by standard protocol with some modifications as follows [@B42]. Tissues were washed with PBS containing 1% penicillin/streptomycin (P/S) (Gibco-BRL, USA). After removing red blood cells, the human adipose tissue was digested overnight in PBS supplemented with 0.01% (w/v) collagenase type I (Gibco-BRL) at 37 °C. The suspension was centrifuged at 1200 RPM for 10 min, and the pellet was washed several times with PBS. The isolated cells were incubated in K-SFM (Invitrogen, USA) supplemented with 10% fetal bovine serum (FBS, Gibco-BRL) and 1% P/S at 37 °C under 5% CO~2~. The hASCs were tested for potential multi-lineage differentiation of adipogenesis, osteogenesis, and chondrogenesis as previous report [@B37], [@B42], [@B43], [@B44].

2.2. Flow cytometry {#Section2.2}
-------------------

The phenotype of hASCs was analyzed by flow cytometry using a Partec flow cytometry. The following mAbs were used : CD34 (1:200, BioLegend, USA), CD44 (1:200, BioLegend, USA), CD45 (1:200, BioLegend, USA), CD90 (1:200, BioLegend, USA), CD105 (1:200, BioLegend, USA). Freshly isolated hASCs were incubated with primary antibody in 200μl PBS for 20 minutes, followed by another incubation with FITC-conjugated secondary antibody in 200μl for 20 minutes in the dark. After two wash steps, the cells were re-suspended in 500 μl PBS and analyzed.

2.3. Cell seeding in HA gel, proliferation and MTT assay {#Section2.3}
--------------------------------------------------------

The 4^th^ passages hASCs (2X10^7^cells/ml) in 1 ml tube was centrifuged at 1200rpm for 5 min to have a high-density cell pellet. This pellet was resuspended in 0.2ml DMEM. hASCs were labeled with chloromethyl-benzamido 1,1\'-dioctadecyl-3,3,3\',3\'- tetramethylindocarbocyanine perchlorate (CellTracker^®^ CM-DiI; Invitrogen, Life Technologies) according to the manufacturer\'s instruction for visualization. Cell suspension 0.2ml was mixed with 0.2 ml sterile RESTYLANE^®^ and placed in a 6-well ultra low culture plate (Corning, USA). Medium was changed every two day. Adhesion of hASCs on the HA gel surface was evaluated under inverted light microscopy (ECLIPSE TS100 inverted microscope, Nikon Corporation). In proliferation studies, two groups HA-hASCs and hASCs alone group were allocate to MTT assay. The MTT ( (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)) substrate is prepared in a Phosphate buffered saline (PBS), added to cells in culture, final concentration of 0.5mg/ml, and incubated for 4 hours at 37°C. After use Dimethyl sulfoxide (DMSO) to each well to dissolve formazan crystals. The quantity of formazan (presumably directly proportional to the number of viable cells) is measured by recording changes in absorbance at 570 nm using a plate reading spectrophotometer.

2.4. Animal models {#Section2.4}
------------------

Guidelines established by the Laboratory Animal Center of Kaohsiung Medical University for the care and use of laboratory animals were observed during all animal experiments. Immunodeficient male mice (BALB/cAnNCrj-nu/nu, six weeks old 20 gm) were purchased from BioLASCO Taiwan Co. Ltd. The another hASCs were cultured in adipogenic induction medium (IDI-I medium and insulin cocktail) for 2 weeks *in vitro*as previous report, with CM-DiI stain [@B37]. This study were allocate with three groups, one is HA-hASCs group, inducted hASCs (0.2ml, 1X10^7^ cells/mL) were mixed with culture medium (DMEM 0.2ml) and HA gel (0.2ml) then injected into the subcutaneous pockets in the back of immunodeficient mice using a 1ml syringe with 19-gauge needle under analgesia. The other two groups were inducted hASCs alone group (0.2ml, 1X10^7^ cells/mL with 0.2ml DMEM) and HA gel alone group (0.2ml HA gel with 0.2ml DMEM). Each mice received one samples (n=6 in each group).

2.5. Hematoxylin-eosin stain, Oil-Red O stain and immunohistochemical staining {#Section2.5}
------------------------------------------------------------------------------

All mice (n=18) were sacrificed at 8 weeks postoperatively with overdose analgesic. The implants were carefully harvested, and the transplanted mixture was weighed using a top-loading balance (Precisa XB 320M). The tissue samples were collected and fixed in 4% paraformaldehyde, perpendicular section was done of 8μm thickness in optimal cutting temperature (OCT) embedded. Stain with hematoxylin-eosin and Oil-Red O stain according to routine histologic protocol. The tissue sections were observed by microscopy (Nikon, Ti-U, USA).

The specimens were fixed in 10% formalin and subsequently embedded in paraffin. The paraffin-embedded tissues were cut with microtome at 3μm. Slides were deparaffinized and hydration and treated with 0.1 M citrate buffer (pH 6.0) for CD44 in autoclave 121℃ at 8 min. By using 3% hydrogen peroxide for 5 minutes to blocking endogenous peroxidase activity at room temperature. After wash with Tris buffer solution (TBS), the sections were incubated with the primary antibodies anti-rat CD44 (1:100; BioLegend, San Diego, CA) at 4℃ overnight. The sections were washed with TBS. Biotinylated second antibody and peroxidase-conjugated streptavidin for used REAL Envision Detection System (DAKO, Denmark) were applied for 30 minutes each. Finally, sections were incubated in 3,3\'-diaminobenzidine for 5 minutes, followed by hematoxylin counterstaining and mounting with Entellan (Merck, HX247305).

2.6. Alu Polymerase chain reaction (PCR) {#Section2.6}
----------------------------------------

Alu PCR is a method of comparing human and nonhuman tissue. Tissue DNA was purified by DNeasy tissue kit (Qiagen, Valencia, CA, USA) following the manufacturer\'s manual. After genomic DNA extraction, it is suggested to check its quality using agarose gel electrophoresis. Alu PCR was conducted using the PCR-based Alu-Human DNA Typing kit (EDVOTEK^®^; The Biotechnology Education Company^®^, Bethesda, MD, USA). PCR conditions were the following: 94 °C (1 min); four cycles of 94 °C (15 s), 64 °C (15 s), 70 °C (15 s); four cycles of 94 °C (15 s), 61 °C (15 s), 70 °C (15 s); four cycles of 94 °C (15 s), 58 °C ( 15 s), 70 °C (15 s); 60 cycles of 94 °C for (15 s), 55 °C (15 s), 70 °C (15 s); 94 °C (1 min) and 60 °C (5 min). PCR products were electrophoretically separated electrophoresed on a 2.5% agarose gel and visualised by ethidium bromide staining.

3. Results {#Section3}
==========

3.1. hASCs have multilineage differentiation capabilities, HA gel did not inhibit the hASCs proliferation *in vitro* {#Section3.1}
--------------------------------------------------------------------------------------------------------------------

The hASCs were well-differentiated into three lineages (adipocytes, osteocytes, and chondrocytes) (Fig. [1](#F1){ref-type="fig"}). For cell proliferation study, the cells were incubated with HA gel for 1,3,7 days. Figure [2](#F2){ref-type="fig"} shows the hASCs mixed well in the HA gel. After 7 days, the number of hASCs in the HA gel had increased and showed no significantly different with hASCs alone group. This indicated the HA gel didn\'t affect the hASCs proliferation.

3.2 Flow cytometry finding comparable with ASCs {#Section3.2}
-----------------------------------------------

Black histograms represent the fluorescence from control cells incubated with only FITC-conjugated secondary antibody. Red histograms represented the cells incubated with relevant primary antibody. Flow cytometric study of hASCs revealed CD45^-^, CD34^-^, CD44^+^, CD90^+^, CD105^+^ (Fig. [1](#F1){ref-type="fig"}).

3.3 new adipose tissue formed in HA gel with hASCs group {#Section3.3}
--------------------------------------------------------

To assess *in vivo* cell proliferation, adipogenic differentiation, and new adipose tissue formation, HA gel with hASCs or HA gel with culture medium was subcutaneously injected into nude mice. The injected HA gel mixture was easily identified throughout the eight-week experiment and no skin necrosis or inflammatory reaction was noted when the mice were sacrificed at 8 weeks (Fig. [3](#F3){ref-type="fig"}, *above, left*). The experimental group revealed soft round deposits of fat tissue (average size, 0.6\*0.5\*0.3cm) surrounding the residual turbid HA gel, and no signs of fibrosis or cystic space were noted (Fig. [3](#F3){ref-type="fig"}, *below, left*). Besides, in gross view, capillary caliber was increased, and neovascularization was noted near the treated area (Fig. [3](#F3){ref-type="fig"},*below, left*). In the control group, the residual clear HA gel was observed in the subcutaneous area (average size, 0.3\*0.4\*0.2cm) (Fig. [3](#F3){ref-type="fig"}, *above, right* and *below, right*). Weight evaluation was not performed because the borders of the specimens were not clearly delineated.

3.4 newly adipose tissues were positive with Oil-Red O, CD44 and CM-DiI stain {#Section3.4}
-----------------------------------------------------------------------------

The HA gel with hASCs groups exhibited well-organized adipose tissue formation intermingled with HA gel in H&E stain (Fig. [4](#F4){ref-type="fig"}). Frozen sections of graft specimens stained with Oil-Red O demonstrated that these newly formed adipose tissues were rich in lipid deposit. In the immunohistochemical stain showed CD44 positive cell marker and CM-DiI positive in newly adipose tissue (Fig. [4](#F4){ref-type="fig"}).

3.5 Alu gene expressed in newly formed adipose tissue {#Section3.5}
-----------------------------------------------------

The neovascularization suggested that hASC-loaded HA gel could proliferate to adipogenesis and form new adipose tissue. To verify the source of newly formed adipose tissue in the nude mice, the Alu gene was studied. Analysis of newly formed adipose tissues by PCR revealed the presence of the Alu gene (Fig. [5](#F5){ref-type="fig"}).

4. Discussion {#Section4}
=============

Soft tissue fillers are widely used to correct congenital defects [@B45] and acquired soft tissue defects such as those resulting from traumatic lesion, tumor resection, and severe burns [@B46]. Recently, soft-tissue fillers have been used for rejuvenation and to treat soft-tissue defects [@B47], [@B48], [@B49], [@B50], [@B51]. Autologous free fat grafting is widely used for filling soft-tissue and contour defects because of its relatively low cost, easy harvest, low donor site morbidity, and lack of allergic reaction. However, average volume loss after fat autotransplants is reportedly 50 percent [@B10], [@B52]. Each of the various fillers (e.g., hyaluronic acid-based filler, collagen, calcium-based microspheres gel) now available on the market, has advantages and disadvantages. Although Lowe et al. [@B53] showed that hyaluronic acid filler has a low risk of hypersensitive reaction, another comparative study of Restylane^®^ and Zyplast^®^ reported an overall increase in the incidence of severe bruising, swelling, and pain [@B2].

A study by Inamed Corporation indicated that common adverse side effects of human collagen filler include cold-like symptoms, flu-like symptoms and urinary tract infection [@B54]. In Tzikas et al., a 52-month follow-up study of patients treated with calcium hydroxylapatite filler indicated that 80% of the patients experienced side effects at 12 months post-treatment [@B55]. Notably, hydroxylapatite filler is also radiopaque and may interfere with facial radiography [@B2]. Accordingly, cell-based adipose tissue engineering is a newly emerging method with substantial advantages over current treatment methods.

Cell-based adipose tissue engineering studies have focused on using various scaffolds as cell carriers to obtain the appropriate shapes and dimensions of reparative tissues. Essential properties of such scaffolds are controlled degradation and lack of immunogeneticity or cytotoxicity [@B56]. Hyaluronic acid is an essential component of the extracelluar matrix of human tissue. The extracelluar matrix provides a microenvironment for maintaining cell homeostasis and for differentiating tissue properties [@B57], [@B58]. Furthermore, scaffolding can be used as a cell support device upon which cell are seeded, otherwise like our data showed in figure [5](#F5){ref-type="fig"}, the injected hASCs were disappear and cannot detect by Alu gene.[@B59] The hASCs are an attractive source of cells for cell-based tissue engineering for adipogenesis [@B34], [@B37], [@B60]. Thus, scaffold with hASCs is become mutually beneficial for adipose tissue engineering.

The many advantages of hASCs include the ability to obtain large amounts of donor tissue with relatively mild patient discomfort and with limited donor site morbidity. They provide a rich source of multipotent stem cells that can be expanded to large numbers *in vitro* [@B42], [@B44], [@B61]. In our study, the cell surface markers were expressed positive for CD44, CD90, CD105. These results are the same as Zannettino et al report [@B62]. Since CD44 is the primary receptor for hyaluronic acid, its expression by hASCs may influence cell signaling pathways and cellular functions [@B63], [@B64]. This study therefore injected co-cultured hyaluronic acid into subcutaneous areas of immune-deficient mice to provide a suitable microenvironment for hASCs to improve adipogenesis and to generate new adipose tissue. On the other hand, the cell dosage choose 2 x10^7^is according our previous data that uncultured stromal vascular fraction loaded onto scaffolds can be regenerated new adipose tissue *in vitro*.[@B65]

Liu et al. [@B66] reported that disulfide-crosslinked hyaluronan films do not facilitate cellular adhesion and protein adsorption. Techniques developed to improve cell adhesion to thiol-modified hyaluronan include the incorporation of fibronectin domains [@B67] or crosslinked gelatin [@B68]. Tholpady et al. [@B69] established that mature adipocytes maintain their phenotype when cultured in suspension and de-differentiate into a precursor state when cultured under cell-adhesive conditions. Flynn et al. [@B36] later confirmed that cells in non-adhesive-crosslinked hyaluronan-alone constructs had significantly higher GPDH activity level. In the HA gel (RESTYLANE^®^) particles, the molecules are connected to each other. The molecular weight of a HA gel particle is higher than 100 billion. The residence time of HA gel is around 4-14 months according on the tissue of implantation, the concentration of stabilized HA gel and the existence of inflammation reaction. ([www.q-med.com](http://www.q-med.com)) In the current study, microscope observation indicated that HA gel optimized the seeding and proliferation of inducted hASCs over the entire carrier (Fig. [2](#F2){ref-type="fig"}). We speculate that adhesion of hASCs to HA gel does not impact the proliferation and differentiation response. HA gel structure may be a good receptor for CD44 and for adhesion of hASCs.

Histological studies after hematoxylin and eosin (H&E) stain and Oil-Red O stain indicated that all newly formed adipose tissue samples were viable adipocytes with large, intact, and highly uniform vacuole-like spaces with very small cell nuclei. Oil-Red O stain confirmed that these spaces were lipid droplets. Neovascularization with red blood cells in endothelial lumen was also noted between HA gel and new adipose tissue. The newly formed adipose tissue clearly originated via Alu gene expression, which is unique to humans. This result suggested that the new adipose tissue is proliferated by human tissue [@B30], [@B70]. However, in figure [5](#F5){ref-type="fig"}, line 3, the hASCs did not express positive gene, that is because hASCs did not homing in the injection site.

Neovascular vessels supplied these newly formed adipose tissues, which is not possible in free fat grafting due to central fat necrosis caused by poor circulation. The hASCs are also known to secrete vascular endothelial growth factor (VEGF) [@B71], which enhances angiogenesis. Finally, HA gel is biodegradable and bioabsorbable. Its gradual replacement by newly forming adipose tissues eventually (Fig. [4](#F4){ref-type="fig"}) and achieve ideal filler, durable and long-term results.

The limitation of this study is that we did not test the long-term effects (\>8 weeks of follow-up) of complete bioabsorption of HA gel with hASCs on *in vivo* adipogenesis. Long-term use of tissue filler to restore adipose tissue defects and to maintain soft tissue is still problematic. This study indicated that mesenchymal stem cells cultured *in vivo*on HA gel form new adipose tissue and provide a volumetrically stable injectable filler as the HA gel scaffold gradually biodegraded. Further long-term *in vivo* studies are needed to determine when HA gel completely disintegrates after injection [@B33]. Although this method obtained new adipose tissue, the detailed molecular mechanisms whereby HA gel promotes the adipogenesis, proliferation, mobility of inducted stem cells and issue of tumorigenesis [@B72].

5. Conclusion {#Section5}
=============

This study demonstrated not only the successful culture of hASCs on HA gel, but also their full proliferation and differentiation into adipocytes. The newly formed adipose tissue maintains the efficacy of the filler throughout the gradual biodegradation and bioabsorption of the HA gel. This technique is a promising approach for developing long-lasting soft tissue filler that would enable the use of HA gel for autologous hASC transplant.
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![The hASCs were well-differentiated into three cell lineages. Lipid vacuole formation after 2 weeks culture of hASCs in adipogenic medium *(upper row, left).* Positive Oil-Red O stain (X200) *(upper row, middle).* Positive Alcian Blue stain after 2-week culture of hASCs in chondrogenic medium (X200) *(upper row, right).*Positive von Kossa stain after 4-week culture of hASCs in osteogenic medium (X200) *(middle row, left)*. Flow cytometric analysis on hASCs for the expression of CD34, CD45, CD44, CD90, and CD105 was performed (Red). Cells stained with Isotype control IgG were examined as a control (black).](ijmsv12p0154g001){#F1}

![Inverted light microscope image showing hASCs seeding in HA gel. hASCs proliferate and aggregate in HA gel on Day 1,3,7 (X100) (red color indicated hASCs with CM-DiI stain). An MTT assay was used to check hASCs cell proliferation in HA gel. No significantly difference between HA-hASCs and hASCs alone group in MTT assay. Error bars indicated deviation.](ijmsv12p0154g002){#F2}

![Macroscopic appearance of grafts in nude mice. Suspension of HA gel containing hASC was subcutaneously injected into the back of each nude mouse. *(Left)*New adipose tissue formation was noted near the residual HA gel at eight weeks after injection. *(Right)*In the control group, the residual clear HA gel was noted in subcutaneous areas. The ruler represents 2 cm.](ijmsv12p0154g003){#F3}

![Histological examination of the grafts stained by hematoxylin-eosin stain eight weeks after injection of suspension of HA gel with hASCs revealed newly formed adipose tissue. The black stars (\*) indicate adipose tissue (scale bar 50μm). Oil-Red O stain (red arrows) revealed the gradual replacement of degraded HA gel with newly formed adipose tissue (red stain) (scale bar 100μm). In the immunohistochemical stain showed CD44 positive cell marker and CM-DiI positive in newly adipose tissue (scale bar 50μm, 100μm respectively).](ijmsv12p0154g004){#F4}

![Results of PCR analysis of Alu gene in graft specimens. 1 was HA gel with hASCs graft. 2 was HA gel only. 3 was hASCs only. 4 was HA gel with medium. 5 was control group. P was positive control.](ijmsv12p0154g005){#F5}
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